Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110443Source: DataRank Database

Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics is a research paper published in Radiotherapy and Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 4.16)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Philip Sutera ORCID,William Silva Mendes,Bardia Yousefi ORCID,Tom Hrinivich,Matthew P. Deek ORCID

Live enrichment

PubMed:39094629 PMC:PMC11405100 OpenAlex:https://openalex.org/W4401169959

NIBIB NIH HHS

Grant: R01 EB032680

NCI NIH HHS

Grant: U54 CA273956

NCI NIH HHS

Grant: R01 CA271540

NIBIB NIH HHS

Grant: R01 EB028324

NCI NIH HHS

Grant: U01 CA212007

NCI NIH HHS

Grant: U01 CA231776

FWCI

4.16

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11405100/pdf/nihms-2017366.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0167814024007138?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814024007138?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11405100

Fields of Study

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingHumansMaleMachine LearningAgedPositron Emission Tomography Computed TomographyMiddle AgedGlutamate Carboxypeptidase IIAntigens, SurfaceProstatic NeoplasmsNeoplasm MetastasisRadiosurgeryAged, 80 and overRadiomics

MeSH Terms

Machine LearningPositron Emission Tomography Computed TomographyRadiomicsAgedAged, 80 and overAntigens, SurfaceHumansMaleMiddle AgedNeoplasm MetastasisProstatic NeoplasmsRadiosurgeryGlutamate Carboxypeptidase II

Keywords

Prostate cancerMedicineGlutamate carboxypeptidase IIRadiomicsMetastasisPet imagingOncologyInternal medicineRadiologyCancerPositron emission tomographyProstatePsma-pet

Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics

FAIR Checklist

Authors (18)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)